Understanding genetic causes of inherited eye diseases
Official title: Clinical and Molecular Studies in Families With Inherited Eye Disease
Run by National Institutes of Health Clinical Center (CC) · NCT02771236 · Data updated 2026-11-12
This study is trying to find out the genetic reasons behind inherited eye diseases by looking at families with affected members and testing participants aged four and older.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 4 Years to 120 Years |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | National Institutes of Health Clinical Center (CC) NIH |
| Locations | 10 sites (La Jolla, California and 9 other locations) |
| Status | Recruiting |
| Started | October 4, 2016 |
| Main results expected | January 1, 2032 |
| Study ends | January 1, 2032 |
| Registry record updated | November 9, 2026 |
| Trial ID | NCT02771236 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals aged four and older who have an inherited eye disease or have a family member with such a condition.
✕Probably not a fit
Patients with diseases or conditions that mimic inherited eye diseases may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to identify the genetic factors linked to inherited eye diseases by examining families with affected individuals. Participants aged four and older will undergo a comprehensive evaluation, including medical history, eye exams, and genetic testing through blood and saliva samples. The research will focus on various inherited eye conditions, such as cataracts and glaucoma, to better understand their genetic underpinnings. The study will involve up to 5,000 participants from diverse backgrounds to ensure a broad understanding of these conditions.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and treatment options for patients with inherited eye diseases.
How similar studies have gone: Other studies have shown success in identifying genetic causes of inherited diseases, suggesting a promising approach for this research.
Who can join: the full rules
Show full inclusion / exclusion criteria
* INCLUSION CRITERIA: To be eligible, the following inclusion criteria must be met, where applicable; 1. Participant must be four years of age or older. 2. Participant must understand and sign the protocol s informed consent document. 3. Individuals or family members of individuals with inherited eye diseases, either congenital, childhood, or age related. 4. All participants must be able to cooperate with study examination and phlebotomy. EXCLUSION CRITERIA: A participant is not eligible if any of the following exclusion criteria are present: 1. Participant has a disease, infection, or trauma that mimics inherited cataracts, retinal degenerations, glaucoma, etc. 2. Participant has a significant active infection (an infection requiring treatment as determined by the investigator) or a history of chronic or recurrent infections. 3. Participant requires sedation for study purposes.
Where it's running
-
University of California, San Diego
La Jolla, California, United States Recruiting -
National Institutes of Health Clinical Center
Bethesda, Maryland, United States Recruiting -
Eye Research Institute, Zhongshan Ophthalmic Center, Sun Yat Sen University
Guangzhou, China Recruiting -
University of the Philippines
Manila, Philippines Recruiting -
The Filatov Institute of Eye Disease and Tissue Therapy of the National Academy
Odesa, Ukraine Recruiting -
Duke University Eye Center
Durham, North Carolina, United States Withdrawn
Show 4 more locations
-
Aravind Medical Research Foundation
Madurai, India Withdrawn -
Seconda Universita di Napoli
Naples, Italy Withdrawn -
National Centre of Excellence in Molecular Biology, University of the Punjab
Lahore, Pakistan Suspended -
University of Exeter
Exeter, United Kingdom Suspended
Study contacts
- Principal investigator: James F Hejtmancik, M.D. — National Eye Institute (NEI)
- Study coordinator: James F Hejtmancik, M.D.
- Email: f3h@helix.nih.gov
- Phone: (301) 435-1598
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using advanced imaging to study retinal disorders
This study is testing a new imaging technology to see how it can help understand and track changes in the eyes of people with inherited and acquired retinal disorders.
-
Long-term observation of ultra-rare inherited neurological diseases.
This study is looking to learn more about very rare inherited neurological diseases by tracking and collecting information from patients over a long time to see how these conditions change and affect their lives.
-
Identifying blood markers for early pancreatic cancer
This study is trying to find specific blood markers that can help detect early pancreatic cancer in people who are at higher risk.
-
Virtual clinic for genetic counseling in inherited heart diseases
This study is testing a new online genetic counseling service for families of people with inherited heart diseases to see if it gets more relatives involved compared to traditional in-person counseling.
-
Safety and dosing of PUMCH-E111 for RLBP1-related inherited retinal dystrophy
A one-eye injection study tests whether PUMCH-E111 can be safely given and help vision for people with RLBP1-related inherited retinal dystrophy.
-
Prevalence of Pediatric Eating Disorders in Children with Inherited Metabolic Diseases
This study is trying to find out how common eating disorders are in young children with inherited metabolic diseases who are on special diets.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.